Martin Posch

Austria

Research Interests

Explore related searches

Professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (11)

Andrew Hooker

Professor of Pharmacometrics

Uppsala University

SWEDEN

View details

Ulrich Sax

Univ-Prof. Dr., Head of Translational Research Informatics Research Group

Universitätsmedizin Göttingen

GERMANY

View details

Ulrich Mansmann

Ludwig-Maximilians-Universität München

GERMANY

View details

James Wason

Professor at Population Health Sciences Institute

Newcastle University

UNITED KINGDOM

View details

Mats Karlsson

Professor

Uppsala University

SWEDEN

View details

I. Steiner

AUSTRIA

View details

Tobias Fellinger

Österreichische Agentur für Gesundheit und Ernährungssicherheit Geschäftsfeld Medizinmarktaufsicht

AUSTRIA

View details

Thomas Jaki

Professor of Computational Statistics

University of Regensburg

GERMANY

View details

Stefan Gold

Professor

Charité - Universitätsmedizin Berlin

GERMANY

View details

Wolfgang Jacquet

Vrije Universiteit Brussel

BELGIUM

View details

Raluca Pais

Sorbonne Université

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Martin Posch

Research Interests

Explore related searches

Contact this professor

Articles (19)

Design Considerations for a Phase II Platform Trial in Major Depressive Disorder

Transforming the evidence landscape in mental health with platform trials

A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards

Resuscitative endovascular balloon occlusion of the aorta for trauma patients with uncontrolled hemorrhage: A retrospective target trial emulation (the AT-REBOA target trial)

Statistical Modeling to Adjust for Time Trends in Adaptive Platform Trials Utilizing Non-Concurrent Controls

Quantitative Comparisons of Progressive Supranuclear Palsy Rating Scale Versions Using Item Response Theory

Innovative approaches for vaccine trials as a key component of pandemic preparedness – a white paper

Regulatory Issues of Platform Trials: Learnings from EU‐PEARL

Implementing clinical trial data sharing requires training a new generation of biomedical researchers

Vaccine Development during a Pandemic: General Lessons for Clinical Trial Design

Online error rate control for platform trials

Are early post‐discharge physician contacts associated with 30‐day psychiatric re‐hospitalisation? A nationwide claims data based retrospective cohort study in Austria free of immortal time bias

Comparing maximum diameter and volume when assessing the growth of small abdominal aortic aneurysms using longitudinal CTA data: cohort study.

On the use of non-concurrent controls in platform trials: a scoping review.

Nationwide analysis of hospital admissions and outcomes of patients with SARS-CoV-2 infection in Austria in 2020 and 2021.

Testing and Interpreting the “Right” Hypothesis—Comment on “Non-proportional Hazards — An Evaluation of the MaxCombo Test in Cancer Clinical Trials”

Red blood cell transfusion-related eicosanoid profiles in intensive care patients-A prospective, observational feasibility study.

Review article: The need for more efficient and patient-oriented drug development pathways in NASH-setting the scene for platform trials.

Rationale for the update algorithm of the graphical approach to sequentially rejective multiple test procedures

Collaborators (11)

Andrew Hooker

Ulrich Sax

Ulrich Mansmann

James Wason

Mats Karlsson

I. Steiner

Tobias Fellinger

Thomas Jaki

Stefan Gold

Wolfgang Jacquet

Raluca Pais

Make your next move.